Markku Jalkanen (born 1954) is a scientist, biotech entrepreneur and businessman from Turku, Finland. He is the CEO of Faron Pharmaceuticals, a Finnish biopharmaceutical company listed on London's Alternative Investment Market. Jalkanen was the founding CEO and President of Biotie Therapies, the first publicly traded biotech-company in Finland. He is an advisor for the Finnish life-science fund, Inveni Capital.
Property | Value |
---|---|
dbo:abstract |
|
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink |
|
dbp:wikiPageUsesTemplate | |
dcterms:subject | |
schema:sameAs | |
rdf:type | |
rdfs:comment |
|
rdfs:label |
|
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:isPrimaryTopicOf | |
is dbo:foundedBy of | |
is dbo:keyPerson of | |
is dbo:wikiPageDisambiguates of | |
is dbo:wikiPageWikiLink of | |
is foaf:primaryTopic of |